Asthma Clinical Trial
Official title:
A Pilot Stress Management Intervention for High Risk Children With Asthma
| Verified date | January 2016 |
| Source | University of Pittsburgh |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | United States: Institutional Review Board |
| Study type | Interventional |
The purpose of the proposed study is to conduct a randomized controlled pilot trial of a school-based stress management and coping skills training program among a sample of economically disadvantaged urban 8- to 12-year-old school children with physician-confirmed asthma. The investigators aim (1) to establish feasibility of this approach by recruiting from different schools and (2) to learn whether individuals assigned to receive the intervention show improvements in psychological function, decreases in lung inflammation, and related improvements in asthma health when compared with disease severity-matched peers who receive education-only or standard care.
| Status | Completed |
| Enrollment | 111 |
| Est. completion date | November 2015 |
| Est. primary completion date | July 2015 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 8 Years to 14 Years |
| Eligibility |
Inclusion Criteria: - In grades 3 through 8 and attending one of the 11 participating public schools - Age 8 through 14 years - Qualify for the free or reduced cost school lunch program in Pennsylvania (families that receive food stamps or have an annual income of < $40,900). - Meets National Heart Lung and Blood Institute (NHLBI, 2007) criteria for any asthma diagnosis EXCEPT mild, intermittent asthma, as confirmed by the study physician using NHLBI Guidelines for the Diagnosis and Management of Asthma (http://www.nhlbi.nih.gov/guidelines/asthma/asthsumm.pdf, page 40). - Has a parent or legal guardian who is willing to participate in the study - Fluent in English (i.e., have commonly used English in everyday speaking and reading for at least 10 years) Exclusion Criteria: - History of a chronic illness in addition to asthma (determined by parent or guardian report) - Prescribed medications other than for asthma - Mental retardation or significant developmental delay - Inability to speak or understand English - A diagnosis of mild, intermittent asthma as determined using NHLBI (2007) criteria (see above) - Age less then 8 years or greater than 14 years - Not in grades 3 through 8 - Not qualifying for free or reduced cost school lunches in Pennsylvania - No parent or legal guardian who is willing to participate |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
| Country | Name | City | State |
|---|---|---|---|
| United States | University of Pittsburgh | Pittsburgh | Pennsylvania |
| Lead Sponsor | Collaborator |
|---|---|
| University of Pittsburgh |
United States,
Long KA, Ewing LJ, Cohen S, Skoner D, Gentile D, Koehrsen J, Howe C, Thompson AL, Rosen RK, Ganley M, Marsland AL. Preliminary evidence for the feasibility of a stress management intervention for 7- to 12-year-olds with asthma. J Asthma. 2011 Mar;48(2):162-70. doi: 10.3109/02770903.2011.554941. — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Proportion of Eligible Children who Participate in Study | A measure of the feasibility of offering the "I Can Cope" intervention trial to socioeconomically disadvantaged 8-14 year-old children with physician-confirmed asthma in urban schools. | End of enrollment: estimated 2 years after beginning active enrollment. | No |
| Primary | Participant Drop-out Rates | A measure of the feasibility of offering the "I Can Cope" intervention trial to socioeconomically disadvantaged 8-14 year-old children with physician-confirmed asthma in urban schools. | After final outcome measures are collected: up to 2 1/2 years from beginning of active enrollment. | No |
| Primary | Session Completion Rates | A measure of the feasibility of offering the "I Can Cope" intervention trial to socioeconomically disadvantaged 8-14 year-old children with physician-confirmed asthma in urban schools. | After final participant has completed study: estimated 2 1/2 years after beginning active enrollement. | No |
| Primary | Program Satisfaction Survey | End of Study Participation: up to 5 months from initial enrollment. | No | |
| Primary | Barriers to offering the Intervention in Selected Schools | End of enrollment: estimated 2 years after beginning active enrollment. | No | |
| Primary | Child Depression Inventory | Assess change in symptoms of depression. | Pre and Post Intervention: baseline, up to 4 months later. | Yes |
| Primary | State-Trait Anxiety Inventory for Children | Assess change in symptoms of anxiety and depression. | Pre and Post Intervention: baseline, up to 4 months later. | No |
| Primary | Perceived Stress Scale | Assess change in the degree to which the child perceives current demands as stressful and exceeding his or her ability to cope. | Pre and post intervention: baseline, up to 4 months later. | No |
| Primary | Pediatric Asthma Quality of Life Questionnaire | Assesses asthma-related quality of life. | Pre and Post Intervention: baseline, up to 4 months later. | No |
| Primary | Asthma Self-Management Scale | Parent and child participants will complete the which assesses beliefs that they can perform behaviors to alleviate the child's asthma, including behaviors associated with symptom prevention (e.g., getting to doctor, using medication, and avoiding allergens) as well as symptom management (e.g., staying calm, controlling symptoms, deciding how to manage symptoms). | Pre and Post Intervention: baseline, up to 4 months later. | No |
| Primary | KIDCOPE | Child participants will complete the Kidcope a 10-item measure of different coping strategies. | Pre and Post Intervention: baseline, up to 4 months later. | No |
| Primary | Measure of Current Status (MOCS - Adapted) | In order to measure the effectiveness of stress management training, child participants will complete an adapted version of the 10-item Measure of Current Status assessing perceived self-efficacy for skills targeted by the intervention: the ability to relax, to recognize stress-inducing situations, to be assertive about needs, and to choose appropriate coping responses. | Pre and Post Intervention: baseline, up to 4 months later. | No |
| Primary | Change in Asthma Health from Baseline | The magnitude of intervention-related improvements in the child's asthma health will be measured by change in pulmonary function, exhaled levels of nitric oxide, and symptoms of asthma, as well as number of medical visits, and school absenteeism. | Pre to post-intervention: baseline, up to 4 months later. | No |
| Secondary | Life Events Questionnaire | Assesses life events that have had a negative impact on the child's psychological state. | Baseline | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|